From “inadequate” to “outstanding” in 12 years.
Coventry’s children’s services show that even under intense pressure, improvement is possible with strong leadership, stable governance and relentless focus on children’s outcomes.
In a national system facing rising demand, poverty and workforce strain, that matters.
Children being heard. Stable homes. Long-term reform.
A reminder that culture and consistency still change lives.
🔗 https://t.co/PquFq9DGbz
#ChildrensServices #SocialWork #Ofsted
Prevention doesn’t always look clinical.
The Moreton Men Sports Group, working with Norfolk and Suffolk NHS Foundation Trust, is supporting men through connection, activity and conversation, reducing loneliness and easing pressure on NHS services.
This is community care in action.
See full BBC article - https://t.co/i4wtOrr8hi
#MentalHealth #NHS #CommunityCare
Nearly 1,000 patients and families supported in just one year.
A powerful reminder that at the end of life, care isn’t just clinical; it’s presence, dignity and human connection.
This model from University Hospitals Sussex NHS FT, with @AnneRobsonTrust, shows what happens when systems value companionship as care.
🔗 https://t.co/aYdu9fxYMP
#EndOfLifeCare #NHS #CompassionateCare
Yesterday, we delivered our first webinar of the year on Train the Trainer quality standards in health & social care.
Sending staff to a Train-the-Trainer course is easy.
Building a defensible, safe internal training system is harder.
Certificates can create false confidence unless you control the scope, keep materials current, observe delivery, run QA, and evidence refreshers.
#TrainTheTrainer #CQCCompliance #WorkforceDevelopment @MandTrainUK
Another provider has had its registration revoked.
Different name. Same pattern.
Repeated breaches. Weak capacity assessments. Staffing strain. Closed culture. Concerns raised before, not fully addressed.
Revocation rarely follows one catastrophic event.
It follows drift.
Drift in care planning.
Drift in oversight.
Drift in supervision.
Drift in learning.
Drift in culture.
Eventually the regulator loses confidence that governance can provide assurance.
Revocation is the visible outcome.
Governance maturity is the root cause.
If the regulator walked in tomorrow, could your systems detect drift before they do?
#ClinicalGovernance #CQC #PatientSafety
A proposal to create an NHS Wales “reserve service”, bringing retired clinicians back during peak demand sounds decisive.
But resilience isn’t built by announcement. It depends on governance, revalidation, indemnity, funded training, and integration with long-term workforce planning.
Surge capacity can help. Substituting for structural reform cannot. In healthcare, design determines safety.
https://t.co/3jrexrTGUD
#NHSWales #WorkforcePlanning #PatientSafety
Clinical audits and registries are being repositioned, from compliance reporting to system infrastructure.
@NHSEngland’s new guidance makes it clear: audit data must deliver timely, actionable insight, surface unwarranted variation, and drive improvement at every level. Audit maturity is fast becoming a proxy for governance maturity.
The real question isn’t “Do we participate in audits?”
It’s “Can we show how audit insight changes decisions and outcomes?”
Read more: https://t.co/k9HMU9TRSb
#ClinicalGovernance #PatientSafety #QualityImprovement
A breakthrough drug for motor neurone disease is stopping symptoms for some patients, while others are denied it because of where they live.
Tofersen is approved in the UK and offered free to the NHS, yet access depends on local staffing and capacity.
For families watching function disappear day by day, this postcode lottery isn’t abstract policy; it’s lived “mental torture”.
When a treatment exists but can’t be delivered, the pathway is broken.
https://t.co/v0DogVtDr7 #MND #NHS #HealthEquity #Innovation
One of the first people in the UK to receive a Neuralink brain implant says it “feels magical”.
The technology allows someone with severe paralysis to control a computer simply by thinking, restoring communication and independence.
The potential is extraordinary. But it’s still early-stage research, with limited trial data and unanswered questions about safety, governance, and long-term impact.
Hope matters, but so does evidence.
https://t.co/tf2GNnmLlL
#HealthAI #PatientSafety #MedicalInnovation
A survey of almost 300 of the trust’s most senior doctors carried out in Sept last year criticised managers for being “remote, detached, and invisible”. Two fifths felt safety concerns were not acted on, while 62 per cent said they lacked resources to deliver excellent care.
35% more weight loss than tirzepatide alone and more cardiometabolic benefit, a potential enhancement of menopausal hormone therapy effect. @MayoClinic small retrospective study with matching
https://t.co/LIyNgyWvHL
A new study suggests vaccine trials should include care homes, and it makes sense.
Care home residents are often most at risk from infections, yet they’re usually left out of the trials for vaccines they later receive.
During Covid, not a single care home resident was recruited into trials, despite being prioritised for vaccination.
If we want vaccines to work well for older, frailer people, they need to be part of the research from the start; safely, ethically, and with their voices heard.
Source: BBC Scotland/University of Aberdeen - https://t.co/ROL4VAG6Ql
#PublicHealth #CareHomes #MedicalResearch
The three major global threats to population health are non-communicable diseases (#NCDs), infectious disease outbreaks, and environmental degradation.
A recent Lancet Commission provides a set of priority recommendations to address these threats.
Read now 👉 https://t.co/jPvYuUbr96
The NHS has expanded access to abiraterone for men newly diagnosed with localised prostate cancer in England. Around 8,000 men a year will now benefit from a treatment proven to cut recurrence risk and reduce deaths by up to 40% when used early.
This decision closes a long-standing postcode gap, aligns England with evidence-based practice already established elsewhere in the UK, and shows what’s possible when clinical evidence, patient advocacy, and system leadership align.
Health and social care is not short of progress. it’s short of balance in how stories are told.
Let’s amplify what works.
🔗 https://t.co/oKb9zpBioO
#GoodHealthNews #prostatecancer #NHS #CancerCare
Why do so many apparently healthy people die or get severely ill from infections that would be considered low risk?
For one, we don't have any way of assessing a person's immune system function in the clinic
https://t.co/CshtAxDep9